Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Mar 14;9:1489–1498. doi: 10.2147/OTT.S99931

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Li and Wu. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

miR-32 inhibits NSCLC cell invasion and migration.

Notes: (A and B) H1299 and A549 cells transfected with miR-32 mimics had weak invasion capacity compared with the controls. (C and D) H1299 and A549 cells transfected with miR-32 mimics had significant decreases in MMP-2 and MMP-9 expression. (E and F) Transfection with miR-32 mimics obviously reduced the migration capacity of H1299 and A549 cells. **P<0.01.

Abbreviations: NSCLC, non-small-cell lung cancer; MMP, matrix metalloproteinase; NC, negative control.

miR-32 inhibits NSCLC cell invasion and migration.

Notes: (A and B) H1299 and A549 cells transfected with miR-32 mimics had weak invasion capacity compared with the controls. (C and D) H1299 and A549 cells transfected with miR-32 mimics had significant decreases in MMP-2 and MMP-9 expression. (E and F) Transfection with miR-32 mimics obviously reduced the migration capacity of H1299 and A549 cells. **P<0.01.

Abbreviations: NSCLC, non-small-cell lung cancer; MMP, matrix metalloproteinase; NC, negative control.